Tag: Access to Medicines

AMSTERDAM, THE NETHERLANDS: The Pharmaceutical Accountability Foundation (PAF) today brought a lawsuit against pharmaceutical company AbbVie for unfair, excessive pricing practices on its blockbuster medicine Humira(adalimumab). AbbVie sold €2.3 billion worth of Humira in the Netherlands during its market monopoly (2004-2018). PAF calculated that AbbVie had overcharged the Dutch healthcare...

Farma ter Verantwoording (The Pharmaceutical Accountability Foundation, PAF) had a busy 2022, with several important steps forward in its mission to further affordable access to medicines and medical technologies.  Highlights include: Our first case has ‘paid off’!  The €19.6 million judgement in July 2021 against Leadiant Biosciences by the Dutch competition authority...

The practical meaning of the human right to the highest attainable standard of health has evolved since its first articulation in the Constitution of the World Health Organisation of 1946 and later in the 1966 International Covenant on Economic, Social and Cultural Rights (ICESCR). The most authoritative interpretation of...

Wemos and the Pharmaceutical Accountability Foundation are proud and pleased to receive a donation of 500,000 euros from the Dutch National Postcode Lottery. With this support, we commit to improving access to affordable corona vaccines and medicines for everyone. We strive for a world in which everyone's health takes...

Webinar on Thursday 3 March 3 PM CET Register here How have pharmaceutical companies been performing according to international human rights principles in the pandemic? The Pharmaceutical Accountability Foundation has been monitoring this in our GCCP scorecard, which ranks pharmaceutical companies according to HR principles and international standards. The aim of...

Online event on Thursday 27 January 2022. Register here. The Pharmaceutical Accountability Foundation (PAF; in Dutch: Farma ter Verantwoording) aims to promote equitable, affordable access to medicines. Pharmaceutical companies say they respect the UN Business and human rights principles. But in our GCCP project and scorecard we have found...

We feel inspired by yesterday's engaging event. Panelists shared their stories about using legal strategies for promoting access to medicines, ranging from HIV treatment action campaigns, using human rights to promote access to medicines in Brazil, compulsory licensing in Russia, TRIPS flexibilities, and the possibility of holding pharma accountable...